Azathioprine in inflammatory bowel disease, a safe alternative?
Azathioprine and its metabolite 6-mercaptopurine are effective in the treatment of inflammatory bowel disease. They are mostly used for reduction of the use of steroids, maintenance therapy after remission induction by cyclosporin and treatment of fistulae in Crohn's disease. Adverse effects oc...
Saved in:
| Main Author: | A. A. Tanis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1998-01-01
|
| Series: | Mediators of Inflammation |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1080/09629359891045 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alopecia as the first manifestation of azathioprine myelosuppression in a genetically predisposed patient
by: Debashish Mishra, et al.
Published: (2019-01-01) -
Case Report: Azathioprine-induced Sweet’s syndrome with associated myocardial infarction
by: Natalie Commins, et al.
Published: (2025-05-01) -
A new approach to drug development – the success story of Gertrude Elion, a Nobel laureate
by: M. V. Grigorieva, et al.
Published: (2025-02-01) -
Influence of probiotics and deoxycholate on azathioprine transport in the PAMPA model: insights into pharmacomicrobiomics and interindividual variability in drug response
by: Maja Đanić, et al.
Published: (2025-06-01) -
Cutaneous side effects caused by treatment for inflammatory bowel disease
by: Dino Tarabar, et al.
Published: (2016-01-01)